Individuals with nonfunctional adrenal tumours (NFATs) have a nearly twofold increased risk of incident diabetes relative to those without adrenal tumours, shows research published in the Annals of Internal Medicine.
Restricting use of an artificial pancreas to the evening and nighttime, with standard pump therapy the rest of the time, seems to deliver similar benefits to using one all day and night in patients with Type 1 diabetes, a study suggests.
Research shows that using a glucagon-like peptide-1 receptor agonist instead of a rapid-acting insulin analogue at mealtimes can reduce glycaemic variability in high-risk patients with Type 2 diabetes.
medwireNews: Parathyroid hormone (PTH) levels may be elevated by use of some antihypertensive agents but reduced by others, analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) suggests. The ...
Researchers report a dose–response relationship between body mass index and cardiovascular risk even in severely obese adolescents, making its assessment important to limit further disease progression.
Many children who require insulin treatment on diagnosis with Type 2 diabetes can be weaned off the medication, show findings from the run-in phase of the Treatment Options for Type 2 Diabetes in Adolescents and Youth study.